Diabetes & Alzheimer's Disease

Epidemiological data indicate that a significant portion of the diabetic population exhibits brain changes that are hallmarks of Alzheimer’s disease and vascular dementia. However, direct biological links remain incompletely understood. Here is the latest research in this area.

January 7, 2021
Review

Part 2: Bypassing TBI-Metabolic Surgery and the Link Between Obesity and Traumatic Brain Injury-A Review

Obesity Surgery
T W McGlennonHenry Buchwald
January 14, 2021

Endocrine dysfunction and cognitive impairment

Minerva endocrinologica
Valeria CalsolaroFabio Monzani
January 23, 2021

Synthesis and in vivo evaluation of a radiofluorinated ketone body derivative.

RSC Medicinal Chemistry
Stephanie J MattinglyFrank Wuest
January 21, 2021
Review
Open Access

Beneficial Effects of Epigallocatechin-3-O-Gallate, Chlorogenic Acid, Resveratrol, and Curcumin on Neurodegenerative Diseases.

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Ryuuta FukutomiMamoru Isemura
January 19, 2021

Does Recent Hospitalization Increase Antipsychotic Initiation Among Community Dwellers With Alzheimer's Disease?

Journal of the American Medical Directors Association
Anna HakalaMiia Tiihonen
January 11, 2021

Is SGSH heterozygosity a risk factor for early-onset neurodegenerative disease?

Journal of Inherited Metabolic Disease
Meghan L DouglassKim M Hemsley
January 19, 2021

GSK-3 Inhibitors: A new class of drugs for Alzheimer's Disease Treatment

Current Drug Targets
Dilipkumar PalSatish Balasaheb Nimse
January 20, 2021

Evaluation of Documentation of Admissions into A Geriatrics Unit in Nigeria: 2014-2018

West African Journal of Medicine
O AkoriaO Emore
January 12, 2021
Open Access

Variants in PPP2R2B and IGF2BP3 are associated with higher tau deposition

Brain Communications
Vijay K RamananPrashanthi Vemuri
January 6, 2021

Nicotinamide as a Foundation for Treating Neurodegenerative Disease and Metabolic Disorders

Current Neurovascular Research
Kenneth Maiese
January 15, 2021
Preprint
Open Access

Increased Risk of Autopsy-Proven Pneumonia with Sex, Season and Neurodegenerative Disease.

MedRxiv : the Preprint Server for Health Sciences
Thomas G BeachGeidy E Serrano
January 8, 2021
Preprint
Open Access

Increased Risk of Autopsy-Proven Pneumonia with Sex, Season and Neurodegenerative Disease

MedRxiv : the Preprint Server for Health Sciences
Thomas G BeachG. E. Serrano

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

© 2021 Meta ULC. All rights reserved
/feed-previews/diabetes-and-alzheimers-disease/1fd339f4-7778-4cc3-82b4-3f71b2b8f654